earnings
confidence high
sentiment positive
materiality 0.75
Sotera Health Q3 net revenues +9.1% to $311M; adj EBITDA +12.2%; raises 2025 guidance
Sotera Health Co
2025-Q3 EPS
reported $0.15
vs consensus $0.22
▼ miss
(-32.1%)
- Q3 net revenues rose 9.1% to $311M; net income $48M ($0.17 diluted EPS) vs $17M ($0.06) a year ago.
- Adjusted EBITDA up 12.2% to $164M; Adjusted EPS $0.26 (+$0.09 YoY); constant-currency rev growth 8.0%.
- Nine-month 2025 net revenues $860M (+6.2%); net income $43M includes $34M pending EO settlement charge.
- 2025 guidance: reaffirms constant-currency revenue growth 4.5%-6.0%; raises adj EBITDA growth to 6.75%-7.75%.
- Sterigenics volumes strong; Nordion double-digit growth; Nelson Labs margin expansion.
item 2.02item 9.01
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.